MJP Associates’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,590
| Closed | -$793K | – | 225 |
|
|
2024
Q2 | $793K | Buy |
8,590
+340
| +4% | +$31.4K | 0.17% | 69 |
|
|
2024
Q1 | $788K | Buy |
8,250
+2,075
| +34% | +$198K | 0.17% | 72 |
|
|
2023
Q4 | $471K | Buy |
6,175
+83
| +1% | +$6.33K | 0.13% | 82 |
|
|
2023
Q3 | $422K | Buy |
6,092
+295
| +5% | +$20.4K | 0.12% | 77 |
|
|
2023
Q2 | $547K | Buy |
5,797
+763
| +15% | +$72K | 0.18% | 69 |
|
|
2023
Q1 | $416K | Buy |
5,034
+329
| +7% | +$27.2K | 0.13% | 75 |
|
|
2022
Q4 | $351K | Buy |
4,705
+171
| +4% | +$12.8K | 0.1% | 88 |
|
|
2022
Q3 | $375K | Sell |
4,534
-116
| -2% | -$9.59K | 0.11% | 82 |
|
|
2022
Q2 | $442K | Sell |
4,650
-339
| -7% | -$32.2K | 0.12% | 72 |
|
|
2022
Q1 | $587K | Sell |
4,989
-409
| -8% | -$48.1K | 0.15% | 67 |
|
|
2021
Q4 | $693K | Buy |
5,398
+921
| +21% | +$118K | 0.21% | 65 |
|
|
2021
Q3 | $507K | Buy |
4,477
+55
| +1% | +$6.23K | 0.17% | 72 |
|
|
2021
Q2 | $458K | Sell |
4,422
-42
| -0.9% | -$4.35K | 0.15% | 76 |
|
|
2021
Q1 | $373K | Buy |
4,464
+377
| +9% | +$31.5K | 0.15% | 82 |
|
|
2020
Q4 | $373K | Buy |
+4,087
| New | +$373K | 0.16% | 78 |
|